BENJAMIN F. EDWARDS & COMPANY, INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,000
+20.0%
1000.0%0.00%
Q2 2022$5,000
-66.7%
100
-50.0%
0.00%
-100.0%
Q1 2022$15,000
-37.5%
2000.0%0.00%0.0%
Q4 2021$24,000
+118.2%
200
-63.6%
0.00%0.0%
Q3 2020$11,000
-8.3%
5500.0%0.00%0.0%
Q2 2020$12,000
+71.4%
5500.0%0.00%0.0%
Q1 2020$7,000
-12.5%
5500.0%0.00%0.0%
Q4 2019$8,000
+14.3%
5500.0%0.00%0.0%
Q3 2019$7,000
-85.1%
550
-81.0%
0.00%
-75.0%
Q2 2019$47,000
-6.0%
2,8990.0%0.00%
-20.0%
Q1 2019$50,000
+61.3%
2,899
+26.1%
0.01%
+66.7%
Q4 2018$31,000
-53.0%
2,2990.0%0.00%
-50.0%
Q3 2018$66,000
+4.8%
2,2990.0%0.01%0.0%
Q2 2018$63,000
+53.7%
2,299
+17.4%
0.01%
+50.0%
Q1 2018$41,000
+64.0%
1,958
+52.1%
0.00%
+33.3%
Q4 2017$25,000
+19.0%
1,287
+49.3%
0.00%0.0%
Q3 2017$21,000
+50.0%
8620.0%0.00%
+50.0%
Q2 2017$14,000
+75.0%
862
+56.7%
0.00%
+100.0%
Q1 2017$8,000
+14.3%
5500.0%0.00%0.0%
Q4 2016$7,000
-22.2%
5500.0%0.00%
-50.0%
Q3 2016$9,0005500.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders